Preparation of factor VII-depleted plasma by immunoaffinity chromatography of insolubilized anti-factor VIi
Takamiya, O.; Funahashi, S.; Yoshioka, K.
Medical Laboratory Sciences 43(3): 215-219
1986
ISSN/ISBN: 0308-3616 PMID: 3807677 Document Number: 274399
Document emailed within 1 workday
Related Documents
Shirodkar, M.V.N.; Sehgal, P.B. 2006: Is the anti-sarcoma and anti-viral cytokine "plasma factor" a novel chicken Y-box protein? Indian Journal of Experimental Biology 44(10): 777-782Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Isojima, S.; Koyama, K.; Fujiwara, N. 1982: Purification of human seminal plasma no. 7 antigen by immunoaffinity chromatography on bound monoclonal antibody Clinical and Experimental Immunology 49(2): 449-456
Ruttyn, Y.; Brandin, M.P.; Vijayalakshmi, M.A. 1989: Chromatography of human plasma on aminohexyl Sepharose: separation of factor VIII/vWf and behaviour of factors II, VII, IX and X and antithrombin III Journal of Chromatography 491(2): 299-308
España, F.; Ratnoff, O.D. 1983: Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases Journal of Laboratory and Clinical Medicine 102(1): 31-45
James O' Donnell and Michael Laffan 2001: Elevated Plasma Factor VIII Levels - a Novel Risk Factor for Venous Thromboembolism Clinical Laboratory 47(1-2): 1-6
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Brinkhous, K.M.; Thomas, B.D.; Ibrahim, S.A.; Read, M.S. 1977: Plasma levels of platelet aggregating factor/vom Willebrand factor in various species Thrombosis Research 11(3): 345-355
Baishev, I.M.; Zubairov, D.M. 1986: Effect of a factor XIi inhibitor isolated from kernels of corn on the cold activation of factor VIi in blood plasma Gematologiia i Transfuziologiia 31(4): 32-35
Hernández-Jerónimo, J.; Pérez-Campos, E.; Matadamas, C.ém.; Majluf-Cruz, A. 2003: A new thrombophilia risk factor: the increase of plasma factor VIIi Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(4): 448-457
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Sultan, Y.; Kazatchkine, M.D.; Maisonneuve, P.; Nydegger, U.E. 1984: Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin Lancet 2(8406): 765-768
Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M. 1995: Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants Thrombosis and Haemostasis 73(4): 734-735
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Zuch, A.; Rudobielska, M.; Zwierzowa, W.; Jurgielewicz, E.; Buluk, K. 1972: Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children Pediatria Polska 47(10): 1197-1203
Li, J.; Li, C.; Chai, L.; Gong, W. 2014: Relationship between plasma vascular endothelial growth factor and tumor necrosis factor-alpha and obstructive sleep apnea hypopnea syndrome in children Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(1): 44-48
Xu, Y.; Lorf, T.; Sablinski, T.; Gianello, P.; Bailin, M.; Monroy, R.; Kozlowski, T.; Awwad, M.; Cooper, D.K.; Sachs, D.H. 1998: Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column Transplantation 65(2): 172-179
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
He, W.J.; Hu, Y.; Zhang, X.P.; Hong, M.; Guo, T.; Wei, W.N.; Song, S.J. 2008: Activated protein C ratio, plasma tissue factor activity and activated factor VIi in Chinese patients with coronary heart disease European Journal of Medical Research 13(2): 47-51